AA
LLY icon

Alesco Advisors’s Eli Lilly LLY Stock Holding History

Alesco Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$426K Buy
463
+38
+9% +$38.5K 0.01% 181
2025
Q4 		$457K Sell
425
-91
-18% -$87K 0.01% 143
2025
Q3 		$394K Buy
516
+110
+27% +$81.9K 0.01% 153
2025
Q2 		$316K Buy
406
+75
+23% +$58.3K 0.01% 160
2025
Q1 		$273K Buy
331
+25
+8% +$20.8K 0.01% 161
2024
Q4 		$236K Buy
306
+36
+13% +$29.8K 0.01% 170
2024
Q3 		$239K Buy
270
+2
+0.7% +$1.8K 0.01% 167
2024
Q2 		$243K Buy
+268
New +$214K 0.01% 166

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Alesco Advisors's LLY Position: Q1 2026 in Review

Alesco Advisors increased its Eli Lilly (LLY) stake by 8.9% in Q1 2026, buying an estimated $38.5K and bringing the position to 463 shares worth $426K. The position accounts for 0.01% of the portfolio, ranked #181.

Alesco Advisors first reported a position in LLY in Q2 2024 and has held it in 8 quarters since. The position peaked at $457K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Alesco Advisors held 463 shares of Eli Lilly worth $426K as of Q1 2026.
  • Alesco Advisors bought 38 Eli Lilly shares in Q1 2026, an estimated $38.5K.
  • Eli Lilly made up 0.01% of Alesco Advisors's portfolio in Q1 2026, its #181 holding.
  • Alesco Advisors first reported a position in Eli Lilly in Q2 2024 and has held it in 8 quarters since.
  • Alesco Advisors's Eli Lilly position peaked at $457K in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Alesco Advisors's 13F filing for Q1 2026, filed 13 May 2026.